LAP&P Consultants

What LAP&P Consultants does

LAP&P Consultants is a privately held, Netherlands-based consultancy founded in 1999 and headquartered in Leiden, Zuid Holland. The firm employs approximately 20 staff and operates under the doing-business-as name "LAP&P." Its business is singularly focused on providing pharmacometric services during the preclinical and clinical phases of drug discovery and development, serving pharmaceutical and biotechnology companies as its primary customer segment.

The firm's core offering is model-based decision support applied across the drug development lifecycle. Its underlying technology is pharmacometric modeling — the application of quantitative, population-level pharmacological and statistical models (such as PK/PD and exposure-response frameworks) to inform go/no-go, dose-selection, and trial-design decisions. By embedding these models into preclinical and clinical workflows, LAP&P positions itself as a specialized external provider of model-informed drug development expertise rather than a software vendor; no proprietary software product or API surface is disclosed.

LAP&P's business model is professional-services based: engagements are delivered directly to pharma and biotech sponsors, with pricing not publicly disclosed. The company has no parent, no subsidiaries, no disclosed funding rounds, no partnerships, no certifications, and no public financial reporting. Its go-to-market is implicit — repeat engagements with European pharmaceutical sponsors — and its distribution is direct consulting delivery rather than channel-based. The firm has operated continuously for over two decades without observable expansion, M&A, or product-diversification events in the available source material.

Name

LAP&P Consultants

Legal name

LAP&P Consultants

Website

https://lapp.nl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

LAP&P Consultants is a Leiden, Netherlands-based pharmacometric consulting firm founded in 1999, serving pharmaceutical and biotechnology companies with model-based decision support during preclinical and clinical drug development.

Ownership category

akta.pro rank

Product category

Pharmacometric Consulting Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Pharmacology & Pharmacometrics (Modeling & Simulation) (HLAIALAG)

akta.pro secondary industries

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Formulation & Preclinical CMC Support (Nonclinical) (HLAGAFAL), Drug Discovery (Target ID/Validation & Hit Discovery) (HLAIALAA)

Keywords

• Pharmacometric services
• Drug development consulting
• Model-based drug development
• Clinical pharmacology consulting
• Preclinical drug development

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

LAP&P Consultants provides Pharmacometric Services during the preclinical and clinical phases of drug discovery and development. The firm applies pharmacometric modeling to deliver model-based support of decision making, with the goal of optimizing the development process and accelerating the availability of improved therapies across disease areas.

Product overview

LAP&P Consultants is a service-based company offering a single unified offering of Pharmacometric Services. The services span preclinical and clinical phases of Drug Discovery and Development, providing model-based decision support to optimize drug development processes and accelerate the availability of improved therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmacometric Services

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Certara: Certara is the leading provider of model-informed drug development services and pharmacometric software, with a broad biosimulation platform. It is the most direct competitor to LAP&P in pharmacometric consulting, though considerably larger in scale.
• Simulations Plus: Simulations Plus provides modeling and simulation software and services for pharmacometrics, PBPK, and quantitative systems pharmacology. It is a direct peer offering both software and consulting services to pharma R&D clients.
• Metrum Research Group: Metrum Research Group is a specialized pharmacometric and clinical pharmacology consulting firm supporting model-based drug development. It is a closely comparable boutique competitor to LAP&P in size and service focus.
• Nuventra Pharma Sciences: Nuventra is a clinical pharmacology and pharmacokinetic consulting firm serving small and mid-sized pharma and biotech clients. It is a comparable boutique peer in size, service offering, and target customer segment.
• Cognigen Corporation: Cognigen (now part of Certara) was a pharmacometric consulting firm focused on population PK/PD modeling and simulation. It represents a direct peer in specialized pharmacometric services for pharma and biotech clients.
• Pharsight: Pharsight (now part of Certara) was historically a specialist in population pharmacokinetics and clinical pharmacology consulting. It represents a direct historical peer in pharmacometric services for drug development.

Emerging players

• Lixoft: Lixoft (now part of Simulations Plus) developed the MonolixSuite for population pharmacokinetic modeling and offered related consulting. It is a partial peer combining pharmacometric software with services, comparable to LAP&P's client base.
• Quantics Biostatistics: Quantics is a European biostatistics and pharmacometrics consulting firm serving pharma and biotech clients. It is a regional peer offering overlapping quantitative services in the European market.
• IntiQuan: IntiQuan is a Swiss-based pharmacometric consulting firm specializing in population PK/PD modeling and NONMEM-based analyses. It is a closely comparable European boutique peer targeting pharmaceutical R&D clients.

Broad incumbents

• ICON plc: ICON is a large global CRO with a pharmacometrics and clinical pharmacology practice embedded within its broader clinical development services. It competes with LAP&P for sponsors seeking integrated modeling support within larger clinical programs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/lap&p-consultants

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LAP&P Consultants